Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20 Pain, Postoperative 5 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Neoplasms 4 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Brain Neoplasms 4 Prostatic Neoplasms 3 Myoma 3 Leiomyoma 3 Head and Neck Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Agnosia 3 Stomatitis 2 Skin Neoplasms 2 Postoperative Hemorrhage 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Hemorrhage 2 Fatigue 2 Colonic Neoplasms 2 Chronic Pain 2 Carcinoma, Hepatocellular 2 Water-Electrolyte Imbalance 1 Vulvodynia 1 Uterine Cervical Neoplasms 1

Interventions

Propranolol 6 Prednisolone 3 Timolol 2 Steroids 2 Saline Solution 2 Prednisone 2 Adrenergic beta-Antagonists 2 Urine Specimen Collection 1 Therapeutics 1 Sodium Chloride 1 Sirolimus 1 Nadolol 1 Methylprednisolone 1 Leuprolide 1 Lasers, Semiconductor 1 Imiquimod 1 High-Energy Shock Waves 1 Hepatectomy 1 Gels 1 Bleomycin 1 Biopsy 1 Atenolol 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hemangioma × Sodium Chloride × Clear all

NCT01685398 2023-09-21

Topical Timolol for Superficial Infantile Hemangioma

Mahidol University

Phase 3 Completed

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡